ASCE+ Exosomes by InMode: Revolutionising Regenerative Aesthetics at IMCAS Paris 2025
Sydney, Australia – March 3rd, 2025 – InMode Australia is proud to announce the
showcasing of ASCE+ Exosomes by ExoCoBio at IMCAS Paris 2025, highlighting the latest
advancements in regenerative aesthetics. As the global leader in exosome science, ExoCoBio
presented revolutionary research and real-world applications of ASCE+ Exosomes for skin and hair
rejuvenation.
ASCE+ Exosomes treatments are founded on cutting-edge biotechnology breakthroughs for skin and
scalp rejuvenation and regeneration. Clinically proven and award-winning, ASCE+ Exosomes are key
players in cell-to-cell communication, facilitating the exchange of RNA, proteins, growth factors,
cytokines, and genetic materials between various cell types, including fibroblasts, keratinocytes, and
immune cells. This exchange is critical for tissue repair and the enhancement of skin cells.
InMode Australia and ExoCoBio, a leading cosmeceutical and biopharmaceutical company based in
Korea, have joined forces to introduce cutting-edge exosome solutions to the Australian and New
Zealand markets. ExoCoBio is a distinguished leader in the field of exosome research, development,
and manufacturing. With a dedication to advancing regenerative medicine and life sciences, it has
garnered international recognition for its cutting-edge exosome products. This collaboration marks a
significant milestone in the healthcare and aesthetics industry.
At IMCAS Paris 2025, ExoCoBio was officially recognised as the only exosome company that has
conducted human studies, solidifying its position as the leader in exosome science. Additionally, with
over 100 patents, ExoCoBio is further demonstrating its commitment to innovation and scientific
excellence.
ASCE+ Exosomes have been honoured with the AMWC 2024 Aesthetic Medicine Award for Best
Regenerative Aesthetic Medicine Product, underscoring their transformative impact on the industry.
InMode Australia is excited to bring these innovative treatments to the forefront of the aesthetic
industry, offering practitioners and patients access to the most scientifically validated exosome
technology available.
For more information about ASCE+ Exosomes by InMode, please visit:
https://www.inmode.com.au/pages/asceexosomesbyinmode
About InMode Australia
InMode Australia is a leading provider of medical aesthetic devices harnessing novel radiofrequency
("RF") and light and laser-based technologies. InMode has leveraged its medically-proven minimally-invasive and non-invasive technologies to offer solutions for face and body contouring, skin
rejuvenation, anti-ageing, laser hair removal, women's health and wellness, and pigmented and
vascular lesions. We believe in providing practitioners and clinicians with the tools they need to help
people in feeling their best through real, repeatable and consistent results.
About ExoCoBio
ExoCoBio is a distinguished leader in the field of exosome research, development, and manufacturing. With a dedication to advancing regenerative medicine and life sciences, it has garnered international
recognition for its cutting-edge exosome products. This collaboration marks a significant milestone in the healthcare and aesthetics industry.
Key Facts:
Key Facts:
- Technology: ASCE+ Exosomes use biotechnology breakthroughs to facilitate cell-to-cell communication, enhancing tissue repair and skin regeneration.
- Scientific Excellence: ExoCoBio is the global leader in exosome science, with over 100 patents and the only company conducting human studies in this field.
- Recognition: ASCE+ Exosomes won the AMWC 2024 Aesthetic Medicine Award for Best Regenerative Aesthetic Medicine Product.
- Partnership: InMode Australia has partnered with Korean-based ExoCoBio to introduce cutting-edge exosome solutions to the Australian and New Zealand markets.
- Applications: The technology supports skin rejuvenation, scalp regeneration, and aesthetic medicine advancements.
- Company Overview:
- InMode Australia: A provider of medical aesthetic devices using radiofrequency (RF), laser, and light-based technologies.
- ExoCoBio: A leader in exosome research, development, and manufacturing, focused on regenerative medicine.
For more details, visit:
InMode Australia Website
PR Contact: Kate Boissett (kate.boissett@inmodemd.com
About us:
For more information about InMode Australia, please visit www.inmode.com.au
Contact details:
For PR enquiries, please contact:
Kate BoissettPublic Relations Manager - InMode ANZ
Mobile: 0422 734 621
Phone: (02) 7209 5678
Email: kate.boissett@inmodemd.com
Website: www.inmode.com.au
